Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PTI - PTI Stock Jumps As EU Grants Orphan Drug Designation

PTI - PTI Stock Jumps As EU Grants Orphan Drug Designation

Yumanity Therapeutics Inc Com

PTI stock is moving higher in Tuesday’s session following the news that Proteostasis Therapeutics Inc (NASDAQ:PTI) received orphan drug designation in the EU for PTI-428, its treatment for cystic fibrosis.

Orphan Drug Designation

Boston, Massachusetts-based Proteostasis Therapeutics stock enjoyed a rally in early trade on Tuesday after news came through that its lead candidate PTI-428 has been granted the status of an orphan drug candidate by the European Commission. The product in question is meant for the treatment of cystic fibrosis, and needless to say, it is a major breakthrough for the company.

The ...

Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.

All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.
Stock Information
Company Name: Yumanity Therapeutics Inc Com
Stock Symbol: PTI
Market: NASDAQ
Menu
PTI PTI Quote PTI Short PTI News PTI Articles PTI Message Board
Get PTI Alerts

News, Short Squeeze, Breakout and More Instantly...